| 1152 | A | 204210 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | LANNETT CO INC | 8MEQ | AB | ["AB"] | 2016-03-28 | Mar 28, 2016 | No | No | No | RX | LANNETT CO INC | e2d43b20913c089ac893bf07100f7fd74afecf98015590b482582cf05e8d8736 |
| 1153 | A | 204210 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | LANNETT CO INC | 10MEQ | AB | ["AB"] | 2016-03-28 | Mar 28, 2016 | No | No | No | RX | LANNETT CO INC | 3eb8465232975adc4ee8e7361bbeb96fdac40ea07a6889a7c76a7c6925ef1e3e |
| 1154 | A | 203002 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | LUPIN LTD | 8MEQ | AB | ["AB"] | 2015-12-18 | Dec 18, 2015 | No | No | No | RX | LUPIN LTD | ea0a64d9d2e27a66191f7af5cca64214da500eb679297fb23386b3f33a842ea6 |
| 1155 | A | 203002 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | LUPIN LTD | 10MEQ | AB | ["AB"] | 2015-12-18 | Dec 18, 2015 | No | No | No | RX | LUPIN LTD | e4821d523d8a5ccb6a5dad613f67e0bc161e794b0827bcb9afaf47c7d2cd1a0e |
| 1156 | A | 070980 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | NESHER PHARMS | 10MEQ | | [] | 1987-02-17 | Feb 17, 1987 | No | No | No | DISCN | NESHER PHARMACEUTICALS USA LLC | e83b8c1eb783a382d7f511437553f9193c0400281de6d480e56e3a2d1d25f752 |
| 1157 | A | 204828 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | NOVEL LABS INC | 8MEQ | AB | ["AB"] | 2016-08-16 | Aug 16, 2016 | No | No | No | RX | NOVEL LABORATORIES INC | a4aed50c79f5cd1974db22b26fb3f6a54f9f473445c1b44a3dc4197e32b01004 |
| 1158 | A | 204828 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | NOVEL LABS INC | 10MEQ | AB | ["AB"] | 2016-08-16 | Aug 16, 2016 | No | No | No | RX | NOVEL LABORATORIES INC | 442d1624e36e6feb3fe33542128c90a20355d83d2cabc4eab628336d074c8c8a |
| 1159 | A | 200185 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | PADDOCK LLC | 8MEQ | AB | ["AB"] | 2011-05-18 | May 18, 2011 | No | No | No | RX | PADDOCK LABORATORIES LLC | 6d6bbd5c6f5b654b05f42404c38f9b7854562dbd577df46ac441d5f4f36645d4 |
| 1160 | A | 200185 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | PADDOCK LLC | 10MEQ | AB | ["AB"] | 2011-05-18 | May 18, 2011 | No | No | No | RX | PADDOCK LABORATORIES LLC | 47c2bb00b362af219d2c6b24084d790bdd02b1d99df807a9e31852d79a3b238d |
| 1161 | A | 209026 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | PRINSTON INC | 8MEQ | AB | ["AB"] | 2019-06-11 | Jun 11, 2019 | No | No | No | RX | PRINSTON PHARMACEUTICAL INC | 0a51de76bb5c164ced09f60183b73cf1e584ebb29cf5ff7e56cdf7e8e3d3c949 |
| 1162 | A | 209026 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | PRINSTON INC | 10MEQ | AB | ["AB"] | 2019-06-11 | Jun 11, 2019 | No | No | No | RX | PRINSTON PHARMACEUTICAL INC | e184a52b8d27d8f7c135dafef27ffad928fd1180b3977083a396bd0b85adc44c |
| 1163 | A | 205549 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | STRIDES PHARMA | 8MEQ | AB | ["AB"] | 2015-12-08 | Dec 8, 2015 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 890b12e8bbed6660dc44ea7d16c90004220a908e748375305b946c7ba7d9a4f8 |
| 1164 | A | 205549 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | STRIDES PHARMA | 10MEQ | AB | ["AB"] | 2015-12-08 | Dec 8, 2015 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 5147ecbe78e4d58ad03fa64800d1ec02057fa84aba03774797c01dd8ddabaf6b |
| 1165 | A | 073531 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | TEVA | 8MEQ | | [] | 1996-04-26 | Apr 26, 1996 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | a7e0b34c36ff9b0dc0df2c06c0d0cd7fb441a837d88a743235f7ec949322bd58 |
| 1166 | A | 073532 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | TEVA | 10MEQ | | [] | 1996-04-26 | Apr 26, 1996 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | 68c3c1824af7e037e9b1e0bdcdb4876c9b13dd079c0fbec1310f11636e7d68dd |
| 1167 | A | 201944 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | TRIS PHARMA INC | 8MEQ | AB | ["AB"] | 2016-03-04 | Mar 4, 2016 | No | No | No | RX | TRIS PHARMA INC | cc7da3ae4e8648f8cdbbd632e21596b45cdca5ac5a238aa0a6bc372bb00f18b2 |
| 1168 | A | 201944 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | TRIS PHARMA INC | 10MEQ | AB | ["AB"] | 2016-03-04 | Mar 4, 2016 | No | No | No | RX | TRIS PHARMA INC | e2370f1ece7ce5db7fb47004019b25c9f9bacd0b6ff75703dafef254bcf138cc |
| 1169 | A | 208445 | 001 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | ZYDUS PHARMS | 8MEQ | AB | ["AB"] | 2019-03-11 | Mar 11, 2019 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | 2e5c2d869907f82e09dacd34a51ca7295fd8f9dd347892643554542a49333fcc |
| 1170 | A | 208445 | 002 | POTASSIUM CHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | POTASSIUM CHLORIDE | ZYDUS PHARMS | 10MEQ | AB | ["AB"] | 2019-03-11 | Mar 11, 2019 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | e76bfcf07bd8f59783879851b1d1ee986a0a83fb1896d5d793d702cbe5290d7d |
| 1171 | A | 205268 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | GLENMARK PHARMS LTD | 225MG | AB | ["AB"] | 2017-09-08 | Sep 8, 2017 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | 36f13bedee91a9ae370dcb6db9cd58dea714455c579017649226aa9ac1a455b3 |
| 1172 | A | 205268 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | GLENMARK PHARMS LTD | 325MG | AB | ["AB"] | 2017-09-08 | Sep 8, 2017 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | 5eb682772950020bd33e132cd2d674d4f10dfafd0cb68494f1f19230030854a6 |
| 1173 | A | 205268 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | GLENMARK PHARMS LTD | 425MG | AB | ["AB"] | 2017-09-08 | Sep 8, 2017 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | e5ccba323ff7a3dc7789842c8bdb7140f8922a79280fdb01e0295ec9d9ff762f |
| 1174 | A | 203803 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | MYLAN | 225MG | AB | ["AB"] | 2016-04-29 | Apr 29, 2016 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | e102448783fed9ad6faf29c2256efa2f32d689e14ab85f38a91cc9232b39fa9a |
| 1175 | A | 203803 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | MYLAN | 325MG | AB | ["AB"] | 2016-04-29 | Apr 29, 2016 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | 52dcb83fe3a9cdb45a7d82da50366a4d9e22ff18bc158bc6212b46fd11ed57b4 |
| 1176 | A | 203803 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | MYLAN | 425MG | AB | ["AB"] | 2016-04-29 | Apr 29, 2016 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | b182a538f374823c7bb2c9b86af37824415829edab3fe763ad6c4d835ac73af1 |
| 1177 | A | 078540 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | PAR PHARM | 225MG | AB | ["AB"] | 2010-10-18 | Oct 18, 2010 | No | No | No | RX | PAR PHARMACEUTICAL | b9089665a471676534fbfb71d394e013a0a6091e629d8cb9588b269286edf6fc |
| 1178 | A | 078540 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | PAR PHARM | 325MG | AB | ["AB"] | 2010-10-18 | Oct 18, 2010 | No | No | No | RX | PAR PHARMACEUTICAL | 201dccabfc939b22f043c22256c7d9ebb413d1462f95845120d1ce15fbd1bc5b |
| 1179 | A | 078540 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | PAR PHARM | 425MG | AB | ["AB"] | 2010-10-18 | Oct 18, 2010 | No | No | No | RX | PAR PHARMACEUTICAL | 99280508e5edab7e89842306f44f935e90b82be9df1e5718aef98746f9841bd9 |
| 1180 | A | 205956 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | RISING | 225MG | AB | ["AB"] | 2018-07-02 | Jul 2, 2018 | No | No | No | RX | RISING PHARMA HOLDINGS INC | 696b6c53b7c8ab4120a1bf3388eb7b40808c2004b82e608411ca4fc92aae6c0c |
| 1181 | A | 205956 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | RISING | 325MG | AB | ["AB"] | 2018-07-02 | Jul 2, 2018 | No | No | No | RX | RISING PHARMA HOLDINGS INC | 312163451aa5585f88c0152d42f0ef5c3f1e86f62a0fb66700587d93545124dc |
| 1182 | A | 205956 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | RISING | 425MG | AB | ["AB"] | 2018-07-02 | Jul 2, 2018 | No | No | No | RX | RISING PHARMA HOLDINGS INC | e008eb43a4cdf1014d4b792f7abff220295c609518a3907e100f6ebc23991442 |
| 1183 | A | 210339 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | SINOTHERAPEUTICS INC | 225MG | AB | ["AB"] | 2019-01-04 | Jan 4, 2019 | No | No | No | RX | SINOTHERAPEUTICS INC | d7fb75bb46ebedb7a81d6b9c37c0e57649ea415dc6a894bd6477aab0c6d374c8 |
| 1184 | A | 210339 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | SINOTHERAPEUTICS INC | 325MG | AB | ["AB"] | 2019-01-04 | Jan 4, 2019 | No | No | No | RX | SINOTHERAPEUTICS INC | f8551c6b96c9515ed6a7024b089b9088ff6f00d19f6df67f0d323fedf6a9708c |
| 1185 | A | 210339 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | SINOTHERAPEUTICS INC | 425MG | AB | ["AB"] | 2019-01-04 | Jan 4, 2019 | No | No | No | RX | SINOTHERAPEUTICS INC | 01fb794dc81de28b2f231e42c5ebad40f66b9e4cfcf80998e566e571717ae178 |
| 1186 | A | 212928 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | TWI PHARMS | 225MG | AB | ["AB"] | 2020-06-18 | Jun 18, 2020 | No | No | No | RX | TWI PHARMACEUTICALS INC | f33886336355a3b941c541907b1e0514e4974eb772bcfb84424fb4ba81cc260a |
| 1187 | A | 212928 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | TWI PHARMS | 325MG | AB | ["AB"] | 2020-06-18 | Jun 18, 2020 | No | No | No | RX | TWI PHARMACEUTICALS INC | 0a04036cc36070e6a450c95cae76aae2564bb2dc5fdd8259421150cf063e4d26 |
| 1188 | A | 212928 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | TWI PHARMS | 425MG | AB | ["AB"] | 2020-06-18 | Jun 18, 2020 | No | No | No | RX | TWI PHARMACEUTICALS INC | 79d46c9abe7200a362d65a069336bef5fcf621357fd07f6c9d39d238694f6309 |
| 1189 | A | 212744 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | UPSHER SMITH LABS | 225MG | AB | ["AB"] | 2020-06-25 | Jun 25, 2020 | No | No | No | RX | UPSHER SMITH LABORATORIES LLC | 9ee4685084130784a30f7f31d7040a5d02780dd917afa4165fa4cca9a9b8ae75 |
| 1190 | A | 212744 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | UPSHER SMITH LABS | 325MG | AB | ["AB"] | 2020-06-25 | Jun 25, 2020 | No | No | No | RX | UPSHER SMITH LABORATORIES LLC | 5574415c8192b7b2f30a5f84367140ac430b53b876ce2c6697d0850cbdc87b80 |
| 1191 | A | 212744 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | UPSHER SMITH LABS | 425MG | AB | ["AB"] | 2020-06-25 | Jun 25, 2020 | No | No | No | RX | UPSHER SMITH LABORATORIES LLC | 0ab59627a8fb2db7d16247e4f3dbc7fe012509809a6bcee46c2840f5b864edb2 |
| 1192 | A | 202688 | 001 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | WATSON LABS INC | 225MG | AB | ["AB"] | 2015-08-24 | Aug 24, 2015 | No | No | No | RX | WATSON LABORATORIES INC | 17a3e187aca801cd1e7e0a9e8706fe016e09c7cbb14f2e32e87a0bd0a734ed0c |
| 1193 | A | 202688 | 002 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | WATSON LABS INC | 325MG | AB | ["AB"] | 2015-08-24 | Aug 24, 2015 | No | No | No | RX | WATSON LABORATORIES INC | 3b1b0c1a912147337e3ed66a8efb5b2e6716b8b72d2defca00e46780e24baa25 |
| 1194 | A | 202688 | 003 | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPAFENONE HYDROCHLORIDE | WATSON LABS INC | 425MG | AB | ["AB"] | 2015-08-24 | Aug 24, 2015 | No | No | No | RX | WATSON LABORATORIES INC | 8e2f5bb50f1bbaeb3f2d518d9425a104ebc595deeaf02b634db6fe17e8169c0c |
| 1195 | A | 078494 | 001 | PROPRANOLOL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPRANOLOL HYDROCHLORIDE | ACTAVIS ELIZABETH | 60MG | AB | ["AB"] | 2007-08-10 | Aug 10, 2007 | No | No | No | RX | ACTAVIS ELIZABETH LLC | db4a13ff75b58cb8f1d26645346a4324da9d8d81583b54b211499f36001fd018 |
| 1196 | A | 078494 | 002 | PROPRANOLOL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPRANOLOL HYDROCHLORIDE | ACTAVIS ELIZABETH | 80MG | AB | ["AB"] | 2007-08-10 | Aug 10, 2007 | No | No | No | RX | ACTAVIS ELIZABETH LLC | b361918c6c0ee73e45cb70d5aa0caf396cc432052cfe99ff43f03aa5890dd2a5 |
| 1197 | A | 078494 | 003 | PROPRANOLOL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPRANOLOL HYDROCHLORIDE | ACTAVIS ELIZABETH | 120MG | AB | ["AB"] | 2007-08-10 | Aug 10, 2007 | No | No | No | RX | ACTAVIS ELIZABETH LLC | 87bc774ea989fd7b066dc449b2d0aa67cb5be070632b9c0fc9530cf73af5ac45 |
| 1198 | A | 078494 | 004 | PROPRANOLOL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPRANOLOL HYDROCHLORIDE | ACTAVIS ELIZABETH | 160MG | AB | ["AB"] | 2007-08-10 | Aug 10, 2007 | No | No | No | RX | ACTAVIS ELIZABETH LLC | a7bdf2e73f6d1305a5d74257140106fb4bb76fa5fdfdb800cfbc93a18f7632f0 |
| 1199 | A | 078703 | 001 | PROPRANOLOL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPRANOLOL HYDROCHLORIDE | ADARE PHARMS INC | 60MG | AB | ["AB"] | 2011-07-15 | Jul 15, 2011 | No | No | No | RX | ADARE PHARMACEUTICALS INC | e482e9dc11221deb48164cf39ea6f8a5ca61791c6f1e484cc1dbbbc51c01f3de |
| 1200 | A | 078703 | 002 | PROPRANOLOL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPRANOLOL HYDROCHLORIDE | ADARE PHARMS INC | 80MG | AB | ["AB"] | 2011-07-15 | Jul 15, 2011 | No | No | No | RX | ADARE PHARMACEUTICALS INC | e921b0b2dabd243346a1500dfc49eb025738b271d02000756b655fddc7ab4fa7 |
| 1201 | A | 078703 | 003 | PROPRANOLOL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | PROPRANOLOL HYDROCHLORIDE | ADARE PHARMS INC | 120MG | AB | ["AB"] | 2011-07-15 | Jul 15, 2011 | No | No | No | RX | ADARE PHARMACEUTICALS INC | 0145f21e480aac049519ce99fca8066e7a42610996568c0bbcd8e78f0d2698f1 |